Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline in advanced Parkinson's disease
NCT00955526Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Jul 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Istradefylline in Parkinson's disease (PD) (3 arms), sponsored by Kyowa Kirin. Primary endpoint: Mean total hours of awake time per day spent in the OFF state at 12 weeks. Started Jul 2009; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00955526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955526.